LASA — Lasa Supergenerics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Lasa Supergenerics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	172	23.9	15	7.9	6.97
Net Total Accounts Receivable
Net Total Receivables	210	70.5	71.9	14.9	0.412
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	663	392	379	325	104
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,251	928	863	483	384
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,092	1,639	1,509	1,015	663
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	447	427	489	172	168
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	513	456	542	178	166
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,579	1,183	967	837	496
Total Liabilities & Shareholders' Equity	2,092	1,639	1,509	1,015	663
Total Common Shares Outstanding